1. Home
  2. WOLF vs EVO Comparison

WOLF vs EVO Comparison

Compare WOLF & EVO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • WOLF
  • EVO
  • Stock Information
  • Founded
  • WOLF 1987
  • EVO 1993
  • Country
  • WOLF United States
  • EVO Germany
  • Employees
  • WOLF N/A
  • EVO N/A
  • Industry
  • WOLF Semiconductors
  • EVO Biotechnology: Pharmaceutical Preparations
  • Sector
  • WOLF Technology
  • EVO Health Care
  • Exchange
  • WOLF Nasdaq
  • EVO Nasdaq
  • Market Cap
  • WOLF 1.6B
  • EVO 1.6B
  • IPO Year
  • WOLF 1993
  • EVO 2021
  • Fundamental
  • Price
  • WOLF $7.95
  • EVO $4.49
  • Analyst Decision
  • WOLF Hold
  • EVO Buy
  • Analyst Count
  • WOLF 16
  • EVO 2
  • Target Price
  • WOLF $17.21
  • EVO $5.90
  • AVG Volume (30 Days)
  • WOLF 12.8M
  • EVO 152.3K
  • Earning Date
  • WOLF 01-29-2025
  • EVO 11-06-2024
  • Dividend Yield
  • WOLF N/A
  • EVO N/A
  • EPS Growth
  • WOLF N/A
  • EVO N/A
  • EPS
  • WOLF N/A
  • EVO N/A
  • Revenue
  • WOLF $804,500,000.00
  • EVO $866,665,179.00
  • Revenue This Year
  • WOLF N/A
  • EVO $4.56
  • Revenue Next Year
  • WOLF $42.33
  • EVO $13.44
  • P/E Ratio
  • WOLF N/A
  • EVO N/A
  • Revenue Growth
  • WOLF 4.96
  • EVO N/A
  • 52 Week Low
  • WOLF $6.10
  • EVO $2.85
  • 52 Week High
  • WOLF $47.43
  • EVO $12.00
  • Technical
  • Relative Strength Index (RSI)
  • WOLF 42.67
  • EVO 49.65
  • Support Level
  • WOLF $9.13
  • EVO $4.39
  • Resistance Level
  • WOLF $8.52
  • EVO $4.81
  • Average True Range (ATR)
  • WOLF 0.91
  • EVO 0.13
  • MACD
  • WOLF -0.05
  • EVO -0.05
  • Stochastic Oscillator
  • WOLF 7.01
  • EVO 45.24

About WOLF Wolfspeed Inc.

Wolfspeed Inc is involved in the manufacturing of wide bandgap semiconductors. It is focused on silicon carbide and gallium nitride materials and devices for power and radio-frequency (RF) applications. The company serves applications such as transportation, power supplies, inverters, and wireless systems. Geographically, it derives a majority of its revenue from Europe and the rest from the United States, China, Hong Kong, Asia Pacific, and other regions.

About EVO Evotec SE

Evotec is a drug discovery partnership firm providing solutions to pharmaceutical and biotechnology companies, academic institutions, foundations, and nonprofit organizations. The company offers services in a variety of therapeutic areas, including central nervous system disorders, diabetes, inflammation, oncology, infectious diseases, and women's health. The shared R&D segment, roughly 80% of sales, provides drug discovery and manufacturing services on a typical fee-for-service basis and integrated drug discovery collaborations based on its proprietary, internally developed assets. The Just-Evotec Biologics segment, about 20% of sales, offers CDMO services for biologics. As of 2023, the company has over 5,000 employees and 18 production sites mainly in Europe and the United States.

Share on Social Networks: